484 related articles for article (PubMed ID: 17312186)
1. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
[TBL] [Abstract][Full Text] [Related]
2. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
[TBL] [Abstract][Full Text] [Related]
3. Block of cloned Kv4.3 potassium channels by dapoxetine.
Jeong I; Kim SW; Yoon SH; Hahn SJ
Neuropharmacology; 2012 Jun; 62(7):2261-6. PubMed ID: 22192593
[TBL] [Abstract][Full Text] [Related]
4. Interaction of riluzole with the closed inactivated state of Kv4.3 channels.
Ahn HS; Kim SE; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2006 Oct; 319(1):323-31. PubMed ID: 16815868
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.
Ahn HS; Choi JS; Choi BH; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
Neuroscience; 2005; 133(4):1007-19. PubMed ID: 15964489
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine blocks cloned Kv4.3 potassium channels.
Choi JS; Hahn SJ
Brain Res; 2012 Jul; 1466():15-23. PubMed ID: 22618310
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
Perchenet L; Clément-Chomienne O
J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
[TBL] [Abstract][Full Text] [Related]
8. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
[TBL] [Abstract][Full Text] [Related]
9. Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K+ channels expressed in HEK293 cells.
Hatano N; Ohya S; Muraki K; Giles W; Imaizumi Y
Br J Pharmacol; 2003 Jun; 139(3):533-44. PubMed ID: 12788813
[TBL] [Abstract][Full Text] [Related]
10. Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.
Jeong I; Choi BH; Hahn SJ
Pflugers Arch; 2010 Oct; 460(5):851-62. PubMed ID: 20734202
[TBL] [Abstract][Full Text] [Related]
11. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
[TBL] [Abstract][Full Text] [Related]
12. Open channel block of Kv3.1 currents by fluoxetine.
Sung MJ; Ahn HS; Hahn SJ; Choi BH
J Pharmacol Sci; 2008 Jan; 106(1):38-45. PubMed ID: 18187934
[TBL] [Abstract][Full Text] [Related]
13. State-dependent block of rabbit vascular smooth muscle delayed rectifier and Kv1.5 channels by inhibitors of cytochrome P450-dependent enzymes.
Iftinca M; Waldron GJ; Triggle CR; Cole WC
J Pharmacol Exp Ther; 2001 Aug; 298(2):718-28. PubMed ID: 11454936
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Kv4.2 channels by a peptide isolated from the venom of the giant bird-eating tarantula Theraphosa leblondi.
Ebbinghaus J; Legros C; Nolting A; Guette C; Celerier ML; Pongs O; Bähring R
Toxicon; 2004 Jun; 43(8):923-32. PubMed ID: 15208026
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
[TBL] [Abstract][Full Text] [Related]
16. Voltage- and time-dependent block by perhexiline of K+ currents in human atrium and in cells expressing a Kv1.5-type cloned channel.
Rampe D; Wang Z; Fermini B; Wible B; Dage RC; Nattel S
J Pharmacol Exp Ther; 1995 Jul; 274(1):444-9. PubMed ID: 7616429
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.
Jeong I; Choi BH; Yoon SH; Hahn SJ
Biochem Pharmacol; 2012 Feb; 83(4):497-505. PubMed ID: 22146582
[TBL] [Abstract][Full Text] [Related]
18. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
Lagrutta A; Wang J; Fermini B; Salata JJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
[TBL] [Abstract][Full Text] [Related]
19. Arachidonic acid potently inhibits both postsynaptic-type Kv4.2 and presynaptic-type Kv1.4 IA potassium channels.
Angelova PR; Müller WS
Eur J Neurosci; 2009 May; 29(10):1943-50. PubMed ID: 19453640
[TBL] [Abstract][Full Text] [Related]
20. Effect of psoralen on the cloned Kv3.1 currents.
Sung MJ; Hahn SJ; Choi BH
Arch Pharm Res; 2009 Mar; 32(3):407-12. PubMed ID: 19387585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
